Lowest Price Guaranteed From USD 4,799
The thermostable vaccines market is estimated to be worth $XX billion in 2021 and is expected to grow at compounded annual growth rate (CAGR) of 40% during the forecast period. Data presented by the WHO indicates that the current global vaccination coverage is nearly 85% this is believed to prevent close to three million deaths from diseases, such as diphtheria, tetanus, whooping cough and measles. However, it has been reported that 25% of vaccines are damaged due to cold chain malfunction (improper distribution and shipping). In some countries, about 80% of the drugs are estimated to lose their potency due to inadequate temperature control during their cold chain transportation. For some vaccines, even the slightest variations in temperature / storage conditions can adversely alter product integrity and / or viability. Over time, technological advancements in the methods of biologics development and manufacturing have prompted the developers to explore the potential of thermostable vaccines and thermostable biologics. Thermostable vaccines can be stored at room temperature for prolonged period of time, thereby eliminating the need for cold chain requirements in storage and transportation. This enables reduction in costs incurred during storage and transportation and, subsequently, the overall costs involved in mass immunization projects. In addition, it allows the suppliers to deliver the products in safe and convenient manner even to far-flung destinations.
At present, several biopharmaceutical companies and clinical research institutes are engaged in the development of thermostable vaccines and thermostable biologics, taking into consideration the rising global population, growing demand for vaccines and specific requirements of large-scale immunization initiatives. Moreover, significant efforts are being put into the development of technologies / devices, which enables transition of conventional vaccines to thermostable vaccines. The market has witnessed substantial partnership activity over the last few years. The activity in this segment of the industry has also attracted the attention of both private and public sector investors / investment funds, which have extended financial support to the initiatives of capable developer companies. Driven by the substantial progress in research in thermostable vaccines market, encouraging clinical trial results, and ongoing technological advancement, the thermostable vaccines and thermostable biologics market is anticipated to witness a commendable market growth during the forecast period.
Examples of key companies engaged in thermostable vaccines market (which have also been profiled in this market report; the complete list of companies is available in the full report) include Allena Pharmaceuticals, Amarillo Biosciences, Vaxart, Tiziana Life Sciences, Diabetology (a subsidiary of Proxima Concepts), Biocon and Serum Institute of India. This market report includes an easily searchable excel database of all the companies providing thermostable vaccines and biologics, worldwide.
Several recent developments have taken place in the field of thermostable vaccines market. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.
The "Thermostable Vaccines Market: Distribution by Type of Molecule (Vaccines and Proteins), Target Indications (Covid-19, Diabetes, Enteric Hyperoxaluria, Norovirus Infection and Rotavirus Infection), Type of Therapy, Key Players and Key Geographical Regions (North America, Europe and Asia Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2035" market report features an extensive study of the current market landscape, market size, market forecast and future opportunities for the players involved in the development of thermostable vaccines and biologics for the treatment of a variety of disease conditions. The market research report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in thermostable vaccines market, across different geographies.
Amongst other elements, the market report includes:
One of the key objectives of this market report is to provide a detailed market forecast analysis in order to estimate the existing market size and future opportunity of thermostable vaccines market during the forecast period. Based on multiple parameters, such as target patient population, likely adoption rates and expected pricing, we have provided informed estimates on the financial evolution of the market for the forecast period 2021-2035. For this purpose, we have segmented the future opportunity across the following market segments: Type of Molecule (Vaccines and Proteins), Target Indications (Covid-19, Diabetes, Enteric Hyperoxaluria, Norovirus Infection and Rotavirus Infection), Type of Therapy, Key Players, and Key Geographical Regions (North America, Europe and Asia Pacific and Rest of the World). To account for uncertainties and to add robustness to our model, we have provided three market forecast scenarios, portraying the conservative, base and optimistic tracks of the anticipated industry’s growth.